My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 265

    1.

    Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.

    Herasimtschuk AA, Westrop SJ, Moyle GJ, Downey JS, Imami N.

    J Immune Based Ther Vaccines. 2008 Oct 31;6:7.PMID: 18976455 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy.

    Pires A, Pido-Lopez J, Moyle G, Gazzard B, Gotch F, Imami N.

    Antivir Ther. 2004 Feb;9(1):67-75.PMID: 15040538 [PubMed - indexed for MEDLINE]Related citations

    3.

    Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.

    Carcelain G, Tubiana R, Samri A, Calvez V, Delaugerre C, Agut H, Katlama C, Autran B.

    J Virol. 2001 Jan;75(1):234-41.PMID: 11119593 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    4.

    Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.

    Jansen CA, De Cuyper IM, Steingrover R, Jurriaans S, Sankatsing SU, Prins JM, Lange JM, van Baarle D, Miedema F.

    AIDS. 2005 Jul 22;19(11):1145-54.PMID: 15990567 [PubMed - indexed for MEDLINE]Related citations

    5.

    No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.

    Crane M, Sirivichayakul S, Chang JJ, Avihingsanon A, Ubolyam S, Buranapraditkun S, Thantiworasit P, Wightman F, Locarnini S, Matthews G, Dore GJ, Ruxrungtham K, Lewin SR.

    J Virol. 2010 Mar;84(6):2657-65. Epub 2010 Jan 6.PMID: 20053751 [PubMed - indexed for MEDLINE]Related citations

    6.

    New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.

    Gahery H, Daniel N, Charmeteau B, Ourth L, Jackson A, Andrieu M, Choppin J, Salmon D, Pialoux G, Guillet JG.

    AIDS Res Hum Retroviruses. 2006 Jul;22(7):684-94.PMID: 16831093 [PubMed - indexed for MEDLINE]Related citations

    7.

    Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.

    Zheng NN, McElrath MJ, Sow PS, Hawes SE, Diallo-Agne H, Stern JE, Li F, Mesher AL, Robinson AD, Gottlieb GS, Huang Y, Kiviat NB.

    J Virol. 2007 Sep;81(17):9061-71. Epub 2007 Jun 20.PMID: 17582003 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    8.

    Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.

    Gori A, Trabattoni D, Bandera A, Saresella M, Marchetti G, Gazzola L, Biasin M, Rhodes J, McDade H, Panebianco R, Galli M, Moroni M, Ferrante P, Thomas N, Franzetti F, Bray D, Clerici M.

    Antivir Ther. 2004 Aug;9(4):603-14.PMID: 15456092 [PubMed - indexed for MEDLINE]Related citations

    9.

    Sustained low-dose growth hormone therapy optimizes bioactive insulin-like growth factor-I level and may enhance CD4 T-cell number in HIV infection.

    Andersen O, Hansen BR, Troensegaard W, Flyvbjerg A, Madsbad S, Ørskov H, Nielsen JO, Iversen J, Haugaard SB.

    J Med Virol. 2010 Feb;82(2):197-205.PMID: 20029798 [PubMed - indexed for MEDLINE]Related citations

    10.

    Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.

    Kapogiannis BG, Henderson SL, Nigam P, Sharma S, Chennareddi L, Herndon JG, Robinson HL, Amara RR.

    AIDS Res Hum Retroviruses. 2006 Mar;22(3):272-82.PMID: 16545014 [PubMed - indexed for MEDLINE]Related citations

    11.

    Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.

    Pohling J, Zipperlen K, Hollett NA, Gallant ME, Grant MD.

    BMC Infect Dis. 2010 May 25;10:129.PMID: 20500844 [PubMed - in process]Free PMC ArticleFree textRelated citations

    12.

    Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.

    Jansen CA, Piriou E, De Cuyper IM, van Dort K, Lange JM, Miedema F, van Baarle D.

    Antivir Ther. 2006;11(1):105-16.PMID: 16518966 [PubMed - indexed for MEDLINE]Related citations

    13.

    Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination.

    Imami N, Hardy G, Burton C, Pires A, Pido-Lopez J, Moss R, Gazzard B, Gotch F.

    Immunol Lett. 2001 Nov 1;79(1-2):63-76.PMID: 11595291 [PubMed - indexed for MEDLINE]Related citations

    14.

    Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.

    Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS.

    Chin Med J (Engl). 2006 Dec 5;119(23):1949-57.PMID: 17199938 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    15.

    Dominant ex vivo cross-stimulation of CD8+ T-cells with whole soluble gag protein in HIV-infected subjects.

    Tavernier A, Jennes W, Fransen K, De Roo A, Kestens L.

    J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):548-56.PMID: 16652028 [PubMed - indexed for MEDLINE]Related citations

    16.

    Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.

    Weinberg A, Dickover R, Britto P, Hu C, Patterson-Bartlett J, Kraimer J, Gutzman H, Shearer WT, Rathore M, McKinney R; PACTG 1021 team.

    AIDS. 2008 Nov 12;22(17):2267-77.PMID: 18981766 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    17.

    Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.

    Ondondo BO, Yang H, Dong T, di Gleria K, Suttill A, Conlon C, Brown D, Williams P, Rowland-Jones SL, Hanke T, McMichael AJ, Dorrell L.

    Eur J Immunol. 2006 Oct;36(10):2585-94.PMID: 17013989 [PubMed - indexed for MEDLINE]Related citations

    18.

    Proliferation, but not interleukin 2 production, of Gag-specific CD8+ T cells is associated with low HIV viremia and high CD4 counts in HIV-1-infected Chinese individuals.

    Li H, Chen X, Jin X, Liu Z, Huang X, Cao Z, Guo C, Dong T, Wu H.

    J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):1-8.PMID: 19584740 [PubMed - indexed for MEDLINE]Related citations

    19.

    HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.

    Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, Routy JP, Sekaly RP.

    J Exp Med. 2003 Dec 15;198(12):1909-22.PMID: 14676302 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    20.

    Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.

    Van Gulck ER, Vanham G, Heyndrickx L, Coppens S, Vereecken K, Atkinson D, Florence E, Kint I, Berneman ZN, Van Tendeloo V.

    J Virol. 2008 Apr;82(7):3561-73. Epub 2008 Jan 30.PMID: 18234800 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk